Egalet is a fully integrated specialty pharmaceutical company focused on developing and commercializing treatments for those living with pain. Egalet was founded around its proprietary Guardian™ Technology that can be applied broadly across different classes of pharmaceutical products. Using this technology, Egalet developed ARYMO® ER (morphine sulfate) extended-release tablets C-II, an extended-release morphine product formulated with abuse-deterrent properties, which is marketed and approved for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. In addition, Egalet also markets two other innovative pain products – SPRIX® (ketorolac tromethamine) Nasal Spray, and OXAYDO® (oxycodone HCl, USP) Tablets for oral use only – CII. Egalet will continue to grow through development of products using its proprietary Guardian Technology and business development.